We don't have a scalable, affordable treatment for hepatitis B available to everyone infected worldwide.
open
Global / Unspecified, Global
WS00493
Effective treatments for hepatitis B exist, but cost and access remain out of reach for many of the hundreds of millions of people living with the infection globally, particularly in lower-income regions. Closing this access gap remains unresolved.